Synlait FY23: PBT swings to $20.3m loss, leverage leaps to 4.6x EBITDA

What changed

Revenue fell 20.5% to $1.3b and EBITDA declined 29.7% to $90.7m. The cleaner operating read is PBT, which swung from a $41.6m profit to a $20.3m loss. Reported NPAT of -$4.3m was flattered by a $9.9m profit from discontinued operations; continuing operations posted a $14.1m after-tax loss. Operating cash flow collapsed to $39.0m from $232.9m, cash fell to $9.3m from $14.5m, and gross borrowings rose 19.6% to $423.8m. On the calculation pass, net debt/EBITDA deteriorated to 4.6x from 2.6x. No segment split or dividend was supplied in the extracted excerpts.

What matters

• Leverage direction. Net debt rose to roughly $414.5m while EBITDA shrank, pushing net debt/EBITDA from 2.6x to 4.6x. Management explicitly flags an intended divestment to address the balance sheet, which makes the capital structure, not the P&L, the central issue for FY24.
• Cash conversion broke down. OCF/EBITDA fell from 180.3% to 43.0%. With capex at $48.8m (3.7% of revenue), pre-lease free cash flow swung to a $9.8m outflow from a $179.1m inflow. This is the mechanical source of the leverage deterioration.
• Earnings quality on continuing operations. Stripping out the $9.9m discontinued-operation gain, continuing operations were loss-making on both a PBT and post-tax basis. The "refreshed strategy" framing is explicitly about returning to profitability rather than building on it.

Expectations

No quantified FY24 target, revenue guidance, or EBITDA target is disclosed in the supplied excerpts. Management's qualitative stance is balance-sheet repair through divestment, a strategy refresh, and "getting the basics right." HY23 represented 58.3% of FY23 continuing revenue and the first-half NPAT of $4.8m flipped to an implied $9.1m second-half loss, so momentum deteriorated through the year rather than improving — the release does not support an inflection thesis on the supplied data.

Quality of result

Low-quality print. The reported $4.3m NPAT loss is cushioned by a $9.9m discontinued-operations gain that will not repeat, and the continuing-operations loss of $14.1m is the more representative figure. Inventory rose 7.4% to $250.3m and receivable days lengthened modestly to about 20.8 days from 18.0 days, so working capital absorbed cash rather than releasing it. Because EBITDA is company-defined and the excerpts do not provide a full reconciliation to NPAT, the gap between $90.7m EBITDA and the loss at the bottom line rests on depreciation, interest and tax lines that are not itemised here. The positive implied second-half operating cash inflow of $163.7m is the only durable-looking data point, though capex of 3.7% of revenue against negative FCF means it was not enough to deleverage.

Unresolved

• Which asset is intended for divestment, on what timetable, and what is the expected deleveraging contribution?
• What explains the EBITDA-to-PBT gap — depreciation step-up, higher interest on the $423.8m debt load, or impairments — and how much is structural?
• What drove the inventory build to $250.3m and is it saleable at carrying value, given softer demand referenced in the release?
• Which customer relationships and product categories drove the 20.5% revenue fall, and is the Joyhana UHT cream launch material or incremental?
• Why is there no reference to a dividend in the extracted release, and what is the board's stance while leverage sits at 4.6x?

This briefing cannot assess the viability or valuation of the planned divestment, or the adequacy of covenant headroom, because neither the asset identity nor the lender covenant terms are in the supplied data.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.